Logo

Fujirebio

Fujirebio Europe to Distribute Self-Screen Cervical Cancer Test

The test is designed to detect elevated methylation levels of cervical cancer biomarkers and may be used as a triage follow-up test of HPV-positive women.

Fujirebio Europe, Ohmx.bio Nab $873K Grant to Develop Clinical Third-Generation Sequencing Platform

The firms said that they will initially focus on the development of a portable, modular platform to detect highly polymorphic regions.

Morphotek, Fujirebio to Develop CA125 II Assay as CDx

The companies will validate and commercialize the assay as a companion diagnostic to identify best responders to Morphotek's investigational ovarian cancer treatment.

IP Roundup: Affymetrix, Nabsys, Ohio State U, Fujirebio Win US Patents
Premium

Affymetrix has been awarded

4,000-plus Patient Study Suggests ROCA Test Specific Enough for Use as Ovarian Cancer Screening Dx
Premium

A longitudinal study of the Risk of Ovarian Cancer Algorithm has found that the algorithm in combination with transvaginal ultrasound offers suitable specificity and positive predictive value for it to be used as an ovarian cancer screening test in post-menopausal women.

Oct 19, 2012

UPDATE: Vermillion Repays Quest $5.9M, Ending Companies' Credit Agreement
Premium

Aug 31, 2012

Healthlinx Inks Deal to Sell OvPlex Dx to San Diego-Based Startup Mane Cancer Diagnostics
Premium

Oct 14, 2011

Is Healthlinx Eyeing Purchase of Correlogic's Assets as Part of Move into US Cancer Dx Market?
Premium

Sep 16, 2011

New Data Demonstrates Increased Sensitivity When Vermillion's OVA1 is Used with Imaging
Premium

Sep 9, 2011

FDA Grants Fujirebio 510(k) Approval for ROMA Ovarian Cancer Dx, Potential Rival to Vermillion's OVA1
Premium

Aug 5, 2011

Vermillion Performs 3,920 OVA1 Tests in Q2, But Revenues Fall 9 Percent on Drop in Licensing Income
Premium

Jul 29, 2009

Abbott, Fujirebio Co-Developing HE4/CA125 Dx to Improve Early Ovarian Cancer Detection
Premium

May 4, 2009

BD, Fujirebio Partner on Cancer Dx Assays

Mar 5, 2009

EC Gives New Consortium $3.8M to Develop High-throughput Technology for Biomarker Detection
Premium

Feb 19, 2009

Industry Briefs: Feb 19, 2009
Premium

Feb 17, 2009

BioArray Briefs: 2009.02.17
Premium

Feb 16, 2009

European Consortium Awarded Nearly $4M to Develop Plasma Biomarker Discovery Platform

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.